These likely contribute to the heightened mTOR activity observed in FA− deficient HNSCC cells, thereby stimulating downstream effectors 4E-BP1 and S6 kinases (Figure 2). This evidence concerns the gene MTOR and head and neck squamous cell carcinoma.